Clinical Trial Update: Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Roxadustat for anemia in participants with lower-risk myelodysplastic syndrome and low red blood cell transfusion burden was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndrome

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts), Anemia | Phase 3 | Status: TERMINATED | Results posted: 2024-08-01